Abstract
Isolation of close contact people and negative test certification are used to manage the spread of new coronavirus infections worldwide. These effectively prevent the spread of infection in advance, but they can lead to a decline in socio-economic activity. Thus, the present study quantified the extent to which isolation and negative test certification respectively reduce the risk of infection. To this end, a discrete-time SEIR model was used as the infectious disease model, and equations for calculating the conditional probability of non-infection status given negative test results on two different days were derived. Then the respective non-infection probabilities with two negative PCR test results, and with one negative PCR test result and one antigen test result, were quantified. By substituting initial parameters of the SEIR model into these probabilities, the present study revealed the following: (1) isolating close contact individuals can reduce by 80% the risk of infection during the first five days, but five more days are needed to reduce the risk 10% more, and seven more days to reduce the risk 20% more; and (2) if an individual with a negative PCR test result has a negative antigen test result the next day, then his or her infection probability is between 0.6% and 0.7%. Our results show that five-day isolation has a proportionally greater effect on risk reduction, compared to longer isolation; and thus, if an isolation period of longer than five days is contemplated, both the risk reduction and the negative effects from such increased isolation should be considered. Regarding negative test certification, our results provide those in managerial positions, who must decide whether to accept the risk and hold mass-gathering events, with quantitative information that may be useful in their decision-making.
Competing Interest Statement
Among the outside support for the study, WN and TY report a relationship with Kao Corporation (funding grants); and a relationship with the Nippon Professional Baseball Organization, Yomiuri Giants, Tokyo Yakult Swallows, Japan Professional Football League, and Japan Professional Basketball League (funding grants). Other activities: the study was conducted as part of a comprehensive research project, comprising members from two private companies, Kao Corporation and NVIDIA Corporation, Japan; however, no authors in the study belong to these companies. MM, MK, WN, TY, and SI have attended the new Coronavirus Countermeasures Liaison Council, jointly established by the Nippon Professional Baseball Organization and Japan Professional Football League, as experts without remuneration. WN and TY are advisors to the Japan National Stadium and Japan Professional Football League. The other authors declare no competing interests. The findings and conclusions of this article are solely the responsibility of the authors, and do not represent the official views of any institution.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Mainly the Introduction and Discussion sections have been revised.
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
